Pfizer … “We have an opportunity to deliver better health, better care and better value for patients and partners around the world.”. every stage of life.
Enter your email address so we can get in touch.
Mylan and Upjohn, a division of Pfizer, unveiled the logo and branding for Viatris, the new company that will be formed by combining Mylan and Upjohn.
Save my name, email, and website in this browser for the next time I comment. © The Indian Express Pvt.
Your email address will not be published. Formed through a combination of two highly complementary businesses, Viatris will unite Upjohn’s strong leadership position in China and emerging markets with Mylan’s significant presence in the U.S. and Europe, allowing the new company to have a meaningfully expanded geographic reach for Viatris’ broad product portfolio and future pipeline. Viatris (pronounced ‘viǝ-trīs) is Latin for “three paths,” and the logo visually captures the company’s commitment to access, leadership and partnership. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Future Viatris Executive Chairman and current Mylan Executive Chairman Robert J. Coury said, “Viatris will be focused on creating a more sustainable healthcare journey for patients worldwide while delivering value to all stakeholders for years to come. Viatris is a pharmaceutical company. The new company was named Viatris in November 2019, with access to 165 markets. Mylan and Pfizer’s Upjohn unveil logo and branding for Viatris, Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size, GMP Cleanroom Routine Environmental Monitoring & 21CFR part 11 Data Integrity | 22nd October 2020, Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size | 5th November 2020, https://www.youtube.com/watch?list=PL2g9kxeSfu7TESltzRckCmWq3FFYDwiut&time_continue=64&v=uOvh28X49E8.
The transaction, which was overwhelmingly approved by Mylan shareholders at Mylan’s Extraordinary General Meeting of Shareholders on June 30, 2020, and is expected to close in the fourth quarter of 2020, subject to the satisfaction of certain remaining closing conditions. Viatris (pronounced ‘viǝ-trīs) is Latin for “three paths,” and the logo visually captures the company’s commitment to access, leadership and partnership. Mylan and Pfizer announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris. The two companies will continue to operate as independent, separate organizations until close. VIATRIS PHARMACEUTICALS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Deriving its name from Latin, Viatris embodies the new company’s goal of providing a path—“VIA”—to three—“TRIS”—core goals: expanding access to medicines, leading by innovating to meet patient needs, and being a trusted partner for the healthcare community worldwide.